Global Migraine Headache Drugs Market Size, Status and Forecast 2024-2031

Report ID: 923152 | Published Date: Jan 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Migraine Headache Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Almotriptan
        1.2.3 Eletriptan
        1.2.4 Sumatriptan
        1.2.5 Rizatriptan
        1.2.6 Zolmitriptan
        1.2.7 Naratriptan
        1.2.8 Frovatriptan
        1.2.9 Others
    1.3 Market by Application
        1.3.1 Global Migraine Headache Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Acute Migraine
        1.3.3 Common Migraine
        1.3.4 Classic Migraine
        1.3.5 Chronic Migraine
        1.3.6 Other Migraines
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Migraine Headache Drugs Market Perspective (2016-2027)
    2.2 Migraine Headache Drugs Growth Trends by Regions
        2.2.1 Migraine Headache Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Migraine Headache Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Migraine Headache Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Migraine Headache Drugs Industry Dynamic
        2.3.1 Migraine Headache Drugs Market Trends
        2.3.2 Migraine Headache Drugs Market Drivers
        2.3.3 Migraine Headache Drugs Market Challenges
        2.3.4 Migraine Headache Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Migraine Headache Drugs Players by Revenue
        3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2016-2021)
        3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Migraine Headache Drugs Revenue
    3.4 Global Migraine Headache Drugs Market Concentration Ratio
        3.4.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2020
    3.5 Migraine Headache Drugs Key Players Head office and Area Served
    3.6 Key Players Migraine Headache Drugs Product Solution and Service
    3.7 Date of Enter into Migraine Headache Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Migraine Headache Drugs Breakdown Data by Type
    4.1 Global Migraine Headache Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2022-2027)

5 Migraine Headache Drugs Breakdown Data by Application
    5.1 Global Migraine Headache Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Migraine Headache Drugs Market Size (2016-2027)
    6.2 North America Migraine Headache Drugs Market Size by Type
        6.2.1 North America Migraine Headache Drugs Market Size by Type (2016-2021)
        6.2.2 North America Migraine Headache Drugs Market Size by Type (2022-2027)
        6.2.3 North America Migraine Headache Drugs Market Size by Type (2016-2027)
    6.3 North America Migraine Headache Drugs Market Size by Application
        6.3.1 North America Migraine Headache Drugs Market Size by Application (2016-2021)
        6.3.2 North America Migraine Headache Drugs Market Size by Application (2022-2027)
        6.3.3 North America Migraine Headache Drugs Market Size by Application (2016-2027)
    6.4 North America Migraine Headache Drugs Market Size by Country
        6.4.1 North America Migraine Headache Drugs Market Size by Country (2016-2021)
        6.4.2 North America Migraine Headache Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Migraine Headache Drugs Market Size (2016-2027)
    7.2 Europe Migraine Headache Drugs Market Size by Type
        7.2.1 Europe Migraine Headache Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Migraine Headache Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Migraine Headache Drugs Market Size by Type (2016-2027)
    7.3 Europe Migraine Headache Drugs Market Size by Application
        7.3.1 Europe Migraine Headache Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Migraine Headache Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Migraine Headache Drugs Market Size by Application (2016-2027)
    7.4 Europe Migraine Headache Drugs Market Size by Country
        7.4.1 Europe Migraine Headache Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Migraine Headache Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Migraine Headache Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Migraine Headache Drugs Market Size by Type
        8.2.1 Asia-Pacific Migraine Headache Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Migraine Headache Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Migraine Headache Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Migraine Headache Drugs Market Size by Application
        8.3.1 Asia-Pacific Migraine Headache Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Migraine Headache Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Migraine Headache Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Migraine Headache Drugs Market Size by Region
        8.4.1 Asia-Pacific Migraine Headache Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Migraine Headache Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Migraine Headache Drugs Market Size (2016-2027)
    9.2 Latin America Migraine Headache Drugs Market Size by Type
        9.2.1 Latin America Migraine Headache Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Migraine Headache Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Migraine Headache Drugs Market Size by Type (2016-2027)
    9.3 Latin America Migraine Headache Drugs Market Size by Application
        9.3.1 Latin America Migraine Headache Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Migraine Headache Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Migraine Headache Drugs Market Size by Application (2016-2027)
    9.4 Latin America Migraine Headache Drugs Market Size by Country
        9.4.1 Latin America Migraine Headache Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Migraine Headache Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Migraine Headache Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Migraine Headache Drugs Market Size by Type
        10.2.1 Middle East & Africa Migraine Headache Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Migraine Headache Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Migraine Headache Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Migraine Headache Drugs Market Size by Application
        10.3.1 Middle East & Africa Migraine Headache Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Migraine Headache Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Migraine Headache Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Migraine Headache Drugs Market Size by Country
        10.4.1 Middle East & Africa Migraine Headache Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Migraine Headache Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Migraine Headache Drugs Introduction
        11.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Migraine Headache Drugs Introduction
        11.2.4 Novartis Revenue in Migraine Headache Drugs Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Migraine Headache Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2016-2021)
        11.3.5 Johnson & Johnson Recent Development
    11.4 GSK
        11.4.1 GSK Company Details
        11.4.2 GSK Business Overview
        11.4.3 GSK Migraine Headache Drugs Introduction
        11.4.4 GSK Revenue in Migraine Headache Drugs Business (2016-2021)
        11.4.5 GSK Recent Development
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck Migraine Headache Drugs Introduction
        11.5.4 Merck Revenue in Migraine Headache Drugs Business (2016-2021)
        11.5.5 Merck Recent Development
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Details
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Migraine Headache Drugs Introduction
        11.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2016-2021)
        11.6.5 Eli Lilly Recent Development
    11.7 Teva
        11.7.1 Teva Company Details
        11.7.2 Teva Business Overview
        11.7.3 Teva Migraine Headache Drugs Introduction
        11.7.4 Teva Revenue in Migraine Headache Drugs Business (2016-2021)
        11.7.5 Teva Recent Development
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Details
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Migraine Headache Drugs Introduction
        11.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2016-2021)
        11.8.5 AstraZeneca Recent Development
    11.9 Sun Pharma
        11.9.1 Sun Pharma Company Details
        11.9.2 Sun Pharma Business Overview
        11.9.3 Sun Pharma Migraine Headache Drugs Introduction
        11.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2016-2021)
        11.9.5 Sun Pharma Recent Development
    11.10 Grunenthal
        11.10.1 Grunenthal Company Details
        11.10.2 Grunenthal Business Overview
        11.10.3 Grunenthal Migraine Headache Drugs Introduction
        11.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2016-2021)
        11.10.5 Grunenthal Recent Development
    11.11 Endo Pharmaceuticals
        11.11.1 Endo Pharmaceuticals Company Details
        11.11.2 Endo Pharmaceuticals Business Overview
        11.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction
        11.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2016-2021)
        11.11.5 Endo Pharmaceuticals Recent Development
    11.12 Mylan
        11.12.1 Mylan Company Details
        11.12.2 Mylan Business Overview
        11.12.3 Mylan Migraine Headache Drugs Introduction
        11.12.4 Mylan Revenue in Migraine Headache Drugs Business (2016-2021)
        11.12.5 Mylan Recent Development
    11.13 Bayer
        11.13.1 Bayer Company Details
        11.13.2 Bayer Business Overview
        11.13.3 Bayer Migraine Headache Drugs Introduction
        11.13.4 Bayer Revenue in Migraine Headache Drugs Business (2016-2021)
        11.13.5 Bayer Recent Development
    11.14 Amneal Pharmaceuticals
        11.14.1 Amneal Pharmaceuticals Company Details
        11.14.2 Amneal Pharmaceuticals Business Overview
        11.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction
        11.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2016-2021)
        11.14.5 Amneal Pharmaceuticals Recent Development
    11.15 Apotex
        11.15.1 Apotex Company Details
        11.15.2 Apotex Business Overview
        11.15.3 Apotex Migraine Headache Drugs Introduction
        11.15.4 Apotex Revenue in Migraine Headache Drugs Business (2016-2021)
        11.15.5 Apotex Recent Development
    11.16 Ajanta Pharma
        11.16.1 Ajanta Pharma Company Details
        11.16.2 Ajanta Pharma Business Overview
        11.16.3 Ajanta Pharma Migraine Headache Drugs Introduction
        11.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2016-2021)
        11.16.5 Ajanta Pharma Recent Development
    11.17 Allergan
        11.17.1 Allergan Company Details
        11.17.2 Allergan Business Overview
        11.17.3 Allergan Migraine Headache Drugs Introduction
        11.17.4 Allergan Revenue in Migraine Headache Drugs Business (2016-2021)
        11.17.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Migraine Headache Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Almotriptan
    Table 3. Key Players of Eletriptan
    Table 4. Key Players of Sumatriptan
    Table 5. Key Players of Rizatriptan
    Table 6. Key Players of Zolmitriptan
    Table 7. Key Players of Naratriptan
    Table 8. Key Players of Frovatriptan
    Table 9. Key Players of Others
    Table 10. Global Migraine Headache Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Migraine Headache Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 12. Global Migraine Headache Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 13. Global Migraine Headache Drugs Market Share by Regions (2016-2021)
    Table 14. Global Migraine Headache Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 15. Global Migraine Headache Drugs Market Share by Regions (2022-2027)
    Table 16. Migraine Headache Drugs Market Trends
    Table 17. Migraine Headache Drugs Market Drivers
    Table 18. Migraine Headache Drugs Market Challenges
    Table 19. Migraine Headache Drugs Market Restraints
    Table 20. Global Migraine Headache Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 21. Global Migraine Headache Drugs Market Share by Players (2016-2021)
    Table 22. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Headache Drugs as of 2020)
    Table 23. Ranking of Global Top Migraine Headache Drugs Companies by Revenue (US$ Million) in 2020
    Table 24. Global 5 Largest Players Market Share by Migraine Headache Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Migraine Headache Drugs Product Solution and Service
    Table 27. Date of Enter into Migraine Headache Drugs Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 30. Global Migraine Headache Drugs Revenue Market Share by Type (2016-2021)
    Table 31. Global Migraine Headache Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 32. Global Migraine Headache Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 33. Global Migraine Headache Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 34. Global Migraine Headache Drugs Revenue Market Share by Application (2016-2021)
    Table 35. Global Migraine Headache Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 36. Global Migraine Headache Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 37. North America Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 38. North America Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 39. North America Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 40. North America Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 41. North America Migraine Headache Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. North America Migraine Headache Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Europe Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 44. Europe Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Europe Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 46. Europe Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Europe Migraine Headache Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 48. Europe Migraine Headache Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 49. Asia-Pacific Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 52. Asia-Pacific Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Asia-Pacific Migraine Headache Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 54. Asia-Pacific Migraine Headache Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 55. Latin America Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 56. Latin America Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Latin America Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 58. Latin America Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Latin America Migraine Headache Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Latin America Migraine Headache Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Middle East & Africa Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 64. Middle East & Africa Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 65. Middle East & Africa Migraine Headache Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 66. Middle East & Africa Migraine Headache Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 67. Pfizer Company Details
    Table 68. Pfizer Business Overview
    Table 69. Pfizer Migraine Headache Drugs Product
    Table 70. Pfizer Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 71. Pfizer Recent Development
    Table 72. Novartis Company Details
    Table 73. Novartis Business Overview
    Table 74. Novartis Migraine Headache Drugs Product
    Table 75. Novartis Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 76. Novartis Recent Development
    Table 77. Johnson & Johnson Company Details
    Table 78. Johnson & Johnson Business Overview
    Table 79. Johnson & Johnson Migraine Headache Drugs Product
    Table 80. Johnson & Johnson Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 81. Johnson & Johnson Recent Development
    Table 82. GSK Company Details
    Table 83. GSK Business Overview
    Table 84. GSK Migraine Headache Drugs Product
    Table 85. GSK Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 86. GSK Recent Development
    Table 87. Merck Company Details
    Table 88. Merck Business Overview
    Table 89. Merck Migraine Headache Drugs Product
    Table 90. Merck Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 91. Merck Recent Development
    Table 92. Eli Lilly Company Details
    Table 93. Eli Lilly Business Overview
    Table 94. Eli Lilly Migraine Headache Drugs Product
    Table 95. Eli Lilly Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 96. Eli Lilly Recent Development
    Table 97. Teva Company Details
    Table 98. Teva Business Overview
    Table 99. Teva Migraine Headache Drugs Product
    Table 100. Teva Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 101. Teva Recent Development
    Table 102. AstraZeneca Company Details
    Table 103. AstraZeneca Business Overview
    Table 104. AstraZeneca Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 105. AstraZeneca Recent Development
    Table 106. Sun Pharma Company Details
    Table 107. Sun Pharma Business Overview
    Table 108. Sun Pharma Migraine Headache Drugs Product
    Table 109. Sun Pharma Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 110. Sun Pharma Recent Development
    Table 111. Grunenthal Company Details
    Table 112. Grunenthal Business Overview
    Table 113. Grunenthal Migraine Headache Drugs Product
    Table 114. Grunenthal Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 115. Grunenthal Recent Development
    Table 116. Endo Pharmaceuticals Company Details
    Table 117. Endo Pharmaceuticals Business Overview
    Table 118. Endo Pharmaceuticals Migraine Headache Drugs Product
    Table 119. Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 120. Endo Pharmaceuticals Recent Development
    Table 121. Mylan Company Details
    Table 122. Mylan Business Overview
    Table 123. Mylan Migraine Headache Drugs Product
    Table 124. Mylan Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 125. Mylan Recent Development
    Table 126. Bayer Company Details
    Table 127. Bayer Business Overview
    Table 128. Bayer Migraine Headache Drugs Product
    Table 129. Bayer Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 130. Bayer Recent Development
    Table 131. Amneal Pharmaceuticals Company Details
    Table 132. Amneal Pharmaceuticals Business Overview
    Table 133. Amneal Pharmaceuticals Migraine Headache Drugs Product
    Table 134. Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 135. Amneal Pharmaceuticals Recent Development
    Table 136. Apotex Company Details
    Table 137. Apotex Business Overview
    Table 138. Apotex Migraine Headache Drugs Product
    Table 139. Apotex Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 140. Apotex Recent Development
    Table 141. Ajanta Pharma Company Details
    Table 142. Ajanta Pharma Business Overview
    Table 143. Ajanta Pharma Migraine Headache Drugs Product
    Table 144. Ajanta Pharma Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 145. Ajanta Pharma Recent Development
    Table 146. Allergan Company Details
    Table 147. Allergan Business Overview
    Table 148. Allergan Migraine Headache Drugs Product
    Table 149. Allergan Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
    Table 150. Allergan Recent Development
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Migraine Headache Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Almotriptan Features
    Figure 3. Eletriptan Features
    Figure 4. Sumatriptan Features
    Figure 5. Rizatriptan Features
    Figure 6. Zolmitriptan Features
    Figure 7. Naratriptan Features
    Figure 8. Frovatriptan Features
    Figure 9. Others Features
    Figure 10. Global Migraine Headache Drugs Market Share by Application: 2020 VS 2027
    Figure 11. Acute Migraine Case Studies
    Figure 12. Common Migraine Case Studies
    Figure 13. Classic Migraine Case Studies
    Figure 14. Chronic Migraine Case Studies
    Figure 15. Other Migraines Case Studies
    Figure 16. Migraine Headache Drugs Report Years Considered
    Figure 17. Global Migraine Headache Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 18. Global Migraine Headache Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 19. Global Migraine Headache Drugs Market Share by Regions: 2020 VS 2027
    Figure 20. Global Migraine Headache Drugs Market Share by Regions (2022-2027)
    Figure 21. Global Migraine Headache Drugs Market Share by Players in 2020
    Figure 22. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Headache Drugs as of 2020
    Figure 23. The Top 10 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2020
    Figure 24. Global Migraine Headache Drugs Revenue Market Share by Type (2016-2021)
    Figure 25. Global Migraine Headache Drugs Revenue Market Share by Type (2022-2027)
    Figure 26. North America Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. North America Migraine Headache Drugs Market Share by Type (2016-2027)
    Figure 28. North America Migraine Headache Drugs Market Share by Application (2016-2027)
    Figure 29. North America Migraine Headache Drugs Market Share by Country (2016-2027)
    Figure 30. United States Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Canada Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Migraine Headache Drugs Market Share by Type (2016-2027)
    Figure 34. Europe Migraine Headache Drugs Market Share by Application (2016-2027)
    Figure 35. Europe Migraine Headache Drugs Market Share by Country (2016-2027)
    Figure 36. Germany Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. France Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. U.K. Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Italy Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Russia Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Nordic Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Migraine Headache Drugs Market Share by Type (2016-2027)
    Figure 44. Asia-Pacific Migraine Headache Drugs Market Share by Application (2016-2027)
    Figure 45. Asia-Pacific Migraine Headache Drugs Market Share by Region (2016-2027)
    Figure 46. China Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Japan Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. South Korea Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Southeast Asia Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. India Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Australia Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Migraine Headache Drugs Market Share by Type (2016-2027)
    Figure 54. Latin America Migraine Headache Drugs Market Share by Application (2016-2027)
    Figure 55. Latin America Migraine Headache Drugs Market Share by Country (2016-2027)
    Figure 56. Mexico Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Brazil Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Migraine Headache Drugs Market Share by Type (2016-2027)
    Figure 60. Middle East & Africa Migraine Headache Drugs Market Share by Application (2016-2027)
    Figure 61. Middle East & Africa Migraine Headache Drugs Market Share by Country (2016-2027)
    Figure 62. Turkey Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Saudi Arabia Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. UAE Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. Pfizer Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 66. Novartis Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 67. Johnson & Johnson Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 68. GSK Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 69. Merck Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 70. Eli Lilly Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 71. Teva Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 72. AstraZeneca Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 73. Sun Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 74. Grunenthal Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 75. Endo Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 76. Mylan Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 77. Bayer Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 78. Amneal Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 79. Apotex Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 80. Ajanta Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 81. Allergan Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
Johnson & Johnson
GSK
Merck
Eli Lilly
Teva
AstraZeneca
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Mylan
Bayer
Amneal Pharmaceuticals
Apotex
Ajanta Pharma
Allergan
Frequently Asked Questions
Migraine Headache Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Migraine Headache Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Migraine Headache Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mecobalamin

Market Analysis and Insights: Global Mecobalamin Market
The global Mecobalamin mark ... Read More